EVALUATING THE EFFICACY OF THE COVID-19 BOOSTER VACCINE IN PRODUCING AN EFFECTIVE T-CELL RESPONSE

被引:0
|
作者
Barve, A. [1 ]
Cortazar, J. [2 ]
Mallon, P. W. G. [2 ]
Kenny, G. [2 ]
机构
[1] Univ Coll Dublin, UCD Sch Med, Dublin, Ireland
[2] Univ Coll Dublin, Sch Med, UCD Ctr Expt Pathogen Host Res CEPHR, Dublin, Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S24 / S25
页数:2
相关论文
共 50 条
  • [21] Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
    Mehrotra, Devan, V
    Janes, Holly E.
    Fleming, Thomas R.
    Annunziato, Paula W.
    Neuzil, Kathleen M.
    Carpp, Lindsay N.
    Benkeser, David
    Brown, Elizabeth R.
    Carone, Marco
    Cho, Iksung
    Donnell, Deborah
    Fay, Michael P.
    Fong, Youyi
    Han, Shu
    Hirsch, Ian
    Huang, Ying
    Huang, Yunda
    Hyrien, Ollivier
    Juraska, Michal
    Luedtke, Alex
    Nason, Martha
    Vandebosch, An
    Zhou, Honghong
    Cohen, Myron S.
    Corey, Lawrence
    Hartzel, Jonathan
    Follmann, Dean
    Gilbert, Peter B.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (02) : 221 - +
  • [23] Temporal evolution of humoral and T-cell specific immune response to COVID-19 mRNA vaccine in multiple sclerosis
    Ruggieri, S.
    Tortorella, C.
    Aiello, A.
    Farroni, C.
    Haggiag, S.
    Prosperini, L.
    Cuzzi, G.
    Salmi, A.
    Quartuccio, M. E.
    Vanin, V.
    Altera, A. M. G.
    Garbuglia, A. R.
    Lapa, D.
    Meschi, S.
    Maffongelli, G.
    Bartoli, T. Ascoli
    Galgani, S.
    Nicastri, E.
    Gasperini, C.
    Goletti, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 606 - 607
  • [24] Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a COVID-19 Vaccine Booster?
    Geers, Andrew L.
    Clemens, Kelly S.
    Colagiuri, Ben
    Jason, Emily
    Colloca, Luana
    Webster, Rebecca
    Vase, Lene
    Seig, Mette
    Faasse, Kate
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (08) : 761 - 768
  • [25] Humoral and T- cell response to multiple COVID-19 booster vaccinations in people with MS
    Upcott, M.
    Tallantyre, E. C.
    Scurr, M. J.
    Vickaryous, N.
    Richards, A.
    Anderson, V.
    Baker, D.
    Chance, R.
    Evangelou, N.
    Giovannoni, G.
    Harding, K. E.
    Hibbert, A.
    Ingram, G.
    Jolles, S.
    Jones, M.
    Kang, A. S.
    Loveless, S.
    Moat, S. J.
    Robertson, N. P.
    Rios, F.
    Schmierer, K.
    Willis, M.
    Godkin, A.
    Dobson, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 365 - 366
  • [26] Artificial COVID-19 T-Cell Immunogen
    M. B. Borgoyakova
    L. I. Karpenko
    A. P. Rudometov
    E. V. Starostina
    A. M. Zadorozhny
    L. A. Kisakova
    D. N. Kisakov
    S. V. Sharabrin
    A. A. Ilyichev
    S. I. Bazhan
    Bulletin of Experimental Biology and Medicine, 2023, 175 : 804 - 809
  • [27] T-cell immunophenotyping in COVID-19 pneumonia
    Nematollahi, Pardis
    Ashrafi, Farzaneh
    Darakhshandeh, Ali
    Salmasi, Mehrzad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [28] Artificial COVID-19 T-Cell Immunogen
    Borgoyakova, M. B.
    Karpenko, L. I.
    Rudometov, A. P.
    Starostina, E. V.
    Zadorozhny, A. M.
    Kisakova, L. A.
    Kisakov, D. N.
    Sharabrin, S. V.
    Ilyichev, A. A.
    Bazhan, S. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 175 (06) : 804 - 809
  • [29] An Effective COVID-19 Vaccine Needs to Engage T Cells
    Sauer, Karsten
    Harris, Tim
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] COVID-19 Booster Vaccine Hesitancy in the Emergency Department
    Molina, M.
    Nichol, G.
    Eucker, S.
    Arreguin, M.
    Morse, D.
    Pauley, A.
    Chavez, C.
    O'Laughlin, K.
    Rodriguez, R.
    ANNALS OF EMERGENCY MEDICINE, 2022, 80 (04) : S103 - S103